08 Brandt EtiologyOA Review RheumClinNA
08 Brandt EtiologyOA Review RheumClinNA
08 Brandt EtiologyOA Review RheumClinNA
34 (2008) 531–559
Etiopathogenesis of Osteoarthritis
Kenneth D. Brandt, MDa,b,*, Paul Dieppe, MDc,
Eric L. Radin, MDd
a
Kansas University Medical Center, 5755 Windsor Drive,
Fairway, Kansas City, KS 66205, USA
b
Indiana University School of Medicine, 1100 West Michigan, Indianapolis, IN 64202, USA
c
Nuffield Orthopaedic Centre, Nuffield Department of Orthopaedic Surgery,
Windmill Road, Headington, Oxford, OX3 7LD, UK
d
Tufts University School of Medicine, 6 School St., PO Box 561, Marion, MA 02738, USA
Some of the thoughts expressed in this article are contained in a chapter, ‘‘Neuromuscular
Aspects of Osteoarthritis,’’ written by KDB, that is to be published by Wiley-Blackwell in the
book, Osteoarthritis Pain, edited by D.T. Felson and H-G. Schaible.
* Corresponding author. Kansas University Medical Center, 5755 Windsor Drive,
Fairway, Kansas City, KS 66205.
E-mail address: [email protected] (K.D. Brandt).
0889-857X/08/$ - see front matter Ó 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.rdc.2008.05.011 rheumatic.theclinics.com
532 BRANDT et al
increased water, and excessive swelling. These cartilage changes are accom-
panied by increased stiffness of the subchondral bone. Biochemically, the
disease is characterized by reduction in the proteoglycan concentration,
possible alterations in the size and aggregation of proteoglycans, alteration
in collagen fibril size and weave, and increased synthesis and degradation of
matrix macromolecules.
No more succinctly, 9 years later, at a workshop sponsored by the American
Academy of Orthopaedic Surgeons, the National Institute of Arthritis, Mus-
culoskeletal, and Skin Diseases, the National Institute on Aging, the Arthritis
Foundation, and the Orthopaedic Research and Education Foundation, OA
was redefined as follows [2]:
Fig. 1. Histologic section through a distal interphalangeal joint of a patient who has nodal
osteoarthritis. A prominent dorsal osteophyte is present, but there is no thinning of the articular
cartilage or loss of surface integrity and no thickening of the subchondral bone, which are
pathognomonic features of osteoarthritis. (From The American College of Rheumatology
clinical slide collection. Atlanta (GA): American College of Rheumatology; Ó 1972–2004
American College of Rheumatology Slide Collection. Used wih permission.)
536 BRANDT et al
did not result in loss of cartilage matrix molecules into the culture medium
or damage to the collagen network), the physical perturbation of the chon-
drocytes was associated with changes in expression of genes for aggrecan,
collagen, matrix metalloproteinases, growth factors, and cytokines that
were transduced into metabolic responses [18].
The rate of loading may be more injurious to cartilage than the magnitude
of the load. When normal rabbits were subjected to repeated acute (50 milli-
seconds, onset to peak) impulsive loading of the knee (ie, square-wave load-
ing), the articular cartilage and subchondral bone were damaged. When
applied more gradually, loads of greater magnitude (500 milliseconds, onset
to peak; ie, sine-wave loading) had no adverse effect [19]. Rapid delivery of
load does not permit sufficient time for periarticular muscle, the major shock
absorber protecting the joint, to prepare for and absorb the load [20].
In vitro, a single injurious compression of a cartilage explant resulted in
a 250-fold increase in the expression of the gene for matrix metalloprotei-
nase-3 (stromelysin), a 40-fold increase in the expression of the gene for
ADAMTS-5 (aggrecanase), and a 12-fold increase in the expression of the
gene for tissue inhibitor of matrix metalloproteinases [21]. Changes of this pro-
portion in the quantities of the relevant proteins that are expressed could lead to
breakdown of the articular cartilage matrix. The authors consider the response
of the cartilage in this experiment to be evidence of an attempt by the chondro-
cytes to repair obvious damage induced in vitro, which was manifest by the loss
of cartilage matrix molecules into the culture medium and damage to the col-
lagen network. They suspect the metabolic responses of cartilage to noninjuri-
ous loading represent a similar phenomenon but that the criteria for identifying
cartilage injury were not sufficiently sensitive to detect microdamage.
The effect on joint cartilage of loading forces and of cytokines (eg, tumor
necrosis factor, interleukin-1) may be additive. When explants of normal ar-
ticular cartilage that had been damaged mechanically were co-cultured with
normal joint capsule/synovium, they released higher levels of aggrecanase-
generated products of aggrecan and exhibited higher levels of aggrecanase
than seen in normal cartilage or in damaged cartilage that was cultured in
the absence of joint capsule/synovium [22]. These observations suggest
that, beyond the direct effects of the mechanical insult to the cartilage itself,
capsule/ synovium of the OA joint may contribute to the degradation of the
damaged cartilage in an attempt to heal the joint.
Although dose–response curves that are relevant to loading of joint car-
tilage in vivo are not well defined, the data suggest that the breakdown of
OA cartilage is mediated by matrix metalloproteinases whose production
is stimulated by cytokines, such as interleukin-1 and tumor necrosis factor,
and that these cytokines could be produced by the chondrocytes themselves
in response to mechanical loads. It is reasonable to consider that the process
may be driven by abnormal mechanical stresses on the joint (eg, arising as
a result of muscle weakness or neuropathy) that interfere with protective
muscular reflexes [23] or by ligamentous instability.
538 BRANDT et al
Changes seen in organ culture in vitro are not identical to what happens in
an OA joint in vivo, however. As indicated earlier [7], excessive loading of
a joint will lead to fracture of the bone before it produces obvious damage
to the articular cartilage. Although metalloproteinases can weaken the
mechanical integrity of articular cartilage in OA, mechanical factors seem
to play the major role; pharmacologic inhibition of metalloproteinases has
not been uniformly successful in halting the progression of OA [24,25]. Based
on the readily apparent shards of articular cartilage embedded in OA syno-
vium [26] and the duplication and advance of the tidemark [27,28], much
of the loss of articular cartilage in OA seems to be caused by the breaking
off of enzymatically weakened segments of the joint surface, like icebergs
from a glacier. Although vertical splits (fibrillation) in the proteoglycan-
depleted cartilage can persist without fragmentation of the joint surface,
the thinned cartilage also is subject to deep horizontal splits (Fig. 2) [29].
When these deep horizontal splits join with the common vertical splits, the
result is the breaking off of cartilage shards that may be detected in the syno-
vial fluid before they become incorporated in the synovial membrane, where
they incite inflammation. In addition, endochondral ossification, caused by
the reactivation of the secondary center of ossification, moves toward the
joint surface, duplicating and advancing the tidemark and gradually thinning
Fig. 2. Histologic section of articular cartilage from a rabbit whose hind limb has been
subjected to repetitive impulsive loading (see [19]). In addition to vertical splits (fibrillation)
at the surface, horizontal tears are apparent running near the base of the cartilage. In osteoar-
thritis, when such tears join with the vertical fissures, they result in fragmentation of the joint
surface and are responsible for the presence of particulate cartilage debris in the synovial space
that may become incorporated into the synovial membrane and cause synovitis (as may soluble
breakdown products of cartilage matrix molecules). Safranin O-fast green. Original magnifica-
tion 25. (Courtesy of D.B. Burr, PhD, Indianapolis, IN.)
ETIOPATHOGENESIS OF OSTEOARTHRITIS 539
the cartilage from below [27]. Most of the loss of articular cartilage in OA
seems to be attributable to these two processes.
Fig. 3. Radiographs of a patient who has hip dysplasia that led to osteoarthritis. The radio-
graph on the left was obtained preoperatively. The film on the right, of the same hip, was
obtained 7 years after a successful osteotomy. At surgery, the alignment of the femur was
altered so that the large, inferomedial beak osteophyte was shifted to the load-bearing region
of the joint. Note the marked decrease in subchondral sclerosis and the widening of the joint
space after surgery. (From Maquet P. Biomechanics of the hip as applied to osteoarthritis
and related conditions. Berlin: Springer; 1985. p. 114. With the kind permission of Springer
Science and Business Media, and of Dr. Maquet.)
ETIOPATHOGENESIS OF OSTEOARTHRITIS 541
the joint surfaces [6]. Articular cartilage can withstand up to five times the
peak deformation that occurs with walking, suggesting that normal
subchondral bone can protect it from all but impulsive loads. Bone, like car-
tilage, is viscoelastic; that is, the fluid in the tissue acts to dampen the effects
of loading.
With rapidly applied impulsive loads, however, the viscoelasticity of the
tissue becomes problematic. Viscoelastic damping requires time to have an
effect: fluid must flow. About one third of normal adults are afflicted with
micro-incoordination [6], and in these persons the important muscle-based
protective mechanisms needed to dampen the forces of joint loading are
not fully coordinated. These individuals therefore subject their knees to
impulsive loading during walking. The consequence of impulsive loading
is that the subchondral bone, which is only one tenth as stiff as hyaline
cartilage, takes the brunt of the blow and, along with the calcified cartilage,
sustains microdamage. If this damage is repetitive, it will cause reactivation
of the secondary center of ossification and remodeling of the subchondral
bone, with an advance of the tidemark leading to thinning of the articular
cartilage [27].
sharply reduced turnover of the subchondral bone, but it did not affect bio-
chemical, metabolic, or morphologic changes in the cartilage [58]. Further-
more, although the drug inhibited the formation of subchondral bone,
which is coupled to bone resorption, it had no effect on osteophytes.
Synovitis
The synovial membrane from patients who have advanced OA commonly
exhibits hyperplasia of the lining cell layer and focal infiltration of lympho-
cytes and monocytes. In advanced OA the intensity of the synovitis may
resemble that in rheumatoid arthritis. Synovitis in OA may be caused by
phagocytosis of wear particles of cartilage and bone from the abraded joint
surface [26,69,70]; by release from the cartilage of soluble matrix macromol-
ecules [71] (eg, proteoglycans, collagen, fibronectin fragments); or by the
presence of crystals of calcium pyrophosphate dihydrate or calcium hydroxy-
apatite [72]. In some cases, immune complexes containing antigens derived
from the cartilage matrix may be sequestered in collagenous tissue of the
joint, such as meniscus, leading to chronic low-grade inflammation [73].
Earlier in the course of OA, however, the synovium, even from symptom-
atic patients who have full-thickness ulceration of the articular cartilage,
may be histologically normal, suggesting that the early pain in those cases
is not caused by synovitis [74]. Conversely, the severity of articular cartilage
damage and of synovitis may be as great in patients who have knee OA but
no joint pain as in those who do have knee pain.
In cross-sectional MRI analyses of subjects who had knee OA, synovial
thickening was much more common in subjects who had pain than in those
who were asymptomatic and, among those who had knee pain, was associ-
ated with more severe pain [75]. Furthermore, in a 30-month longitudinal
study of patients who had symptomatic knee OA [76], changes in synovitis,
as graded by MRI, correlated only modestly with changes in knee pain. The
relatively weak correlation suggests that synovitis was not the only or even
the major cause of the joint pain. Furthermore, pain was not correlated with
the loss of articular cartilage in either the tibiofemoral or patellofemoral
compartment, and changes in synovial effusion were not correlated with
changes in pain. In contrast, in a sample of symptomatic subjects from
the Osteoarthritis Initiative, Lo and colleagues [77] found that maximal joint
effusion scores on MRI were highly associated with knee pain even after
adjustment for bone marrow lesion (BML) scores, suggesting that effusion
(a manifestation of underlying synovitis) was associated independently
with knee pain.
548 BRANDT et al
Among the reservations the authors expressed earlier about the success of
pharmacologic modification of joint damage in OA without the establish-
ment of a more favorable local mechanical environment is the uncertainty
that a chondroprotective drug would ameliorate symptoms. If such an agent
stabilized the cartilage surface, it might reduce the component of joint pain
caused by synovitis resulting from the breakdown of cartilage and bone.
There is no reason, however, to believe the agent would reduce pain that
is caused by the reaction to phlogistic breakdown products that already
had been incorporated by the synovium. In addition, in the face of increased
intra-articular stress, it is unlikely that pharmacologic chondroprotection is
feasible.
Subchondral bone
In the early 1970s, Arnoldi and colleagues [78,79] emphasized the impor-
tance of increased intraosseous pressure as a cause of pain in OA. These
investigators demonstrated marked increases in intramedullary pressure
and stasis of medullary blood flow in patients who had hip OA, presumably
caused by the distortion of blood flow through subchondral trabeculae that
had been thickened as a result of remodeling in response to abnormal stress.
Furthermore, normalization of the hemodynamic changes by an osteotomy
(ie, an operation that, without entering the joint, cuts the bone and fixes it
into an alignment that relieves mechanical stress across the joint by decreas-
ing the resultant force on the joint and/or increasing the surface area avail-
able to carry that force) or by any procedure that transects the metaphyseal
bone can alleviate joint pain promptly.
In 1980, Arnoldi and colleagues [80] described 25 patients who had pain in
the hip or knee at rest caused by OA or by intraosseous engorgement-pain syn-
drome who exhibited venous stasis on intraosseous phlebography, increased
intraosseous pressure in the intramedullary space near the painful joint,
and high uptake of 99mtechnetium polyphosphate on bone scintigraphy. In
patients who had other types of pain, these correlations did not exist. The
authors suggested that the similarity of the three findings in patients who
had intraosseous engorgement-pain syndrome and those who had OA
reflected a common pathogenetic mechanism for the patients’ pain.
Notably, McAlindon and colleagues [81], in a 1991 study that correlated
findings on MRI, scintigraphy, and radiography in 12 patients who had
knee OA, found that nine OA knees exhibited diffuse loss of the medial or
lateral tibiofemoral subchondral marrow signal on the proton-density image,
with corresponding hyperintensity on the short tau inversion recovery
sequence, and reported that this MRI abnormality was associated very
strongly with an extended pattern of isotope on bone scintigraphy.
In a cross-sectional scintigraphic study of 100 patients who had knee OA
recruited from a rheumatology clinic, McCrae and colleagues [53] found
a very strong correlation between a pattern of generalized uptake of the
ETIOPATHOGENESIS OF OSTEOARTHRITIS 549
isotope around the joint on the delayed (bone-phase) scan and knee pain.
Similarly, a very strong correlation was observed between isotope retention
in the subchondral bone in late-phase scans and subchondral sclerosis on the
radiograph. Furthermore, Dieppe and colleagues [82] documented the pre-
dictive value of the bone scan for radiographic progression of knee OA, as
reflected by joint-space narrowing. In scans that did not show focal areas of
isotope retention, no progression was noted over a 5-year follow-up period.
In contrast, progression of joint-space narrowing was seen in approximately
50% of patients who had OA and who had a ‘‘hot’’ knee scan at baseline.
Since these reports by Arnoldi and colleagues [80], however, osteotomy
largely has been replaced by arthroplasty as a surgical treatment for symp-
tomatic OA. Nonsurgical treatment of OA pain continues to be based
chiefly on systemic pharmacologic therapy with analgesics and nonselective
or selective NSAIDs that fail to take into account the altered vascular
physiology of the joint.
A recent preliminary report by Hunter and colleagues [83] confirms a link
between elevated intraosseous pressures and BMLs, which are seen com-
monly on MRI of OA knees as focal areas of increased signal in the subchon-
dral marrow in fat-suppressed T2-weighted images. The lesions that now are
called ‘‘BMLs’’ are consistent with the marrow lesions that McAlindon and
colleagues [81] described in 1991 and showed to be associated strongly with
isotope retention on bone scintigraphy. Histologic examination of these
lesions, which erroneously have been called ‘‘bone marrow edema,’’ has
shown them to be foci of fibrosis and of osteonecrosis and bone remodeling
[84]. BMLs are not specific for OA and may be seen with insufficiency frac-
tures, osteonecrosis, and a variety of other conditions. In patients who
have knee OA, they have been associated with varus-valgus malalignment
[85] and the progression of structural damage [81,85], and, in some studies,
with joint pain [53,86].
Using a dynamic contrast-enhanced MRI sequence, Hunter and col-
leagues [83] found that BMLs in patients who had advanced knee OA
were sites of venous hypertension that showed reduced runoff of contrast
material in comparison with the surrounding tissue. Results were consistent
with reduced perfusion, intraosseous venous hypertension, and increased
permeability at sites of BMLs. It is not known whether pharmacologic
agents acting directly on vascular flow would be efficacious in treatment
of OA pain.
However, in a recent uncontrolled trial in 104 patients who had painful
BMLs from a variety of causes, including OA, Meizer and colleagues [87]
found that parenteral administration of iloprost, a stable analogue of pros-
tacyclin, significantly improved pain and decreased the size of the BMLs.
Aigner and colleagues [88] compared results over 11 months in patients
who had bone marrow edema syndrome (with BMLs on MRI but not
necessarily with OA) who were treated with iloprost and in a control group
that was treated with core decompression of the femoral head. Clinical
550 BRANDT et al
strength, reduced joint pain, improved function, and reduced reflex inhibi-
tion of the quadriceps in patients who had knee OA [102]. As reviewed by
Minor [103], longer trials tended to be more effective than shorter ones;
the higher the dose of exercise, the more effective was the intervention;
and only weight-bearing exercise seemed to improve function.
Considerable interest has focused on the importance in knee OA of the
peak adduction moment, which is considered to be a proxy for the dynamic
load on the medial tibiofemoral compartment of the knee [104]. In cross-
sectional studies the peak adductor moment was significantly greater in
patients who had medial compartment knee OA than in controls and also
was significantly greater in patients who had more severe OA than in those
who had less severe disease [105,106]. Peak adductor moment has been
shown to be a strong predictor of radiographic progression in patients
who have medial compartment OA [107] and of the development of knee
pain in asymptomatic older subjects [108]. Chang and colleagues [109]
recently reported that a greater degree of toe-out during gait, which shifts
the ground reaction force vector closer to the center of the knee, thereby re-
ducing the adductor moment, decreased the risk of radiographic progression
of knee OA over 18 months.
In subjects who had relatively mild structural changes of knee OA,
Thorp and colleagues [110] found that those who had knee pain had signif-
icantly higher medial compartment loads than those who were asymptom-
atic; the loads in those who were asymptomatic were no different from
those in normal controls. The results suggest that at this stage of structural
damage, individuals who have symptomatic OA differ biomechanically
from those who have asymptomatic disease. The possibility that the two
groups differed in the prominence of repetitive impulsive loading warrants
consideration.
In gait analyses performed on subjects who had knee OA while they were
wearing their everyday walking shoes and also while walking barefoot, peak
loads at the hips and knees decreased significantly with barefoot walking,
with a nearly 12% reduction in the knee adduction moment [111]. In a recent
preliminary report [112], the same researchers found that a shoe that was
designed to incorporate essential features of natural foot motion reduced
dynamic loading of the medial compartment of the knee during gait.
Finally, Schnitzer and colleagues [113], in a 4-week study of 18 patients
who had symptomatic knee OA and varus deformity, found that treatment
with the NSAID piroxicam reduced the level of joint pain but significantly
increased the adductor moment; that is, it increased loading of the already
damaged medial tibiofemoral compartment. Whether this increase would
have resulted in acceleration of structural damage if treatment had been
maintained for longer periods (possibly because of a faster gait and greater
impulsive loading because of relief of joint pain) is not known. The question
has potential clinical importance, because many patients who have OA pain
are treated with NSAIDs for years.
ETIOPATHOGENESIS OF OSTEOARTHRITIS 553
Summary
The importance of abnormal joint mechanics in the etiopathogenesis of
OA cannot be overemphasized. The authors view OA as a process that is
attempting to contain a mechanical problem in the joint; OA is best defined
as failed repair of joint damage that has been caused by excessive mechan-
ical stress. Because the body’s innate mechanisms for repairing damaged
cartilage cannot deal with the underlying mechanical abnormality, they
cannot solve the problem of OA. Remodeling of the subchondral bone
may reduce the excessive levels of local stress and contain the mechanical
abnormality but also may cause joint pain and reactivate enchondral ossifi-
cation at the expense of the overlying articular cartilage.
The common mechanical factor underlying OA is a pathologic increase in
intra-articular stress, which can result either from a decrease in the load-
bearing area of the joint or a quantitative increase in, or aberration of, joint
loading (ie, repetitive impulsive loading). Impulsive loads cause microinjury
of both the subchondral bone and articular cartilage that may exceed the
ability of the joint to repair the damage.
Although the capacity for intrinsic repair of damaged articular cartilage is
limited, cells that are extrinsic to the cartilage can provide a mechanism for
repair if the local environment permits. The new cartilage they produce, fibro-
cartilage, is not histologically, biochemically, or biomechanically comparable
to normal hyaline articular cartilage, but it nonetheless can permit normal
joint function, prevent further deterioration, and, most importantly, permit
the patient to function asymptomatically. Neither the large role that the reduc-
tion of excessive levels of mechanical stress plays in promoting the healing
response in OA nor the evidence that the relief of joint pain and improvement
of functiondand not the appearance of the articular surfacedare the most
important outcomes of the healing process have been sufficiently emphasized.
On the other hand, excessive emphasis has been placed on the inflamma-
tory changes in OA that, although relevant to the patient’s symptoms, are
secondary to breakdown products of cartilage and bone, and on articular
cartilage as the major focus of OA damage and progression. It must be remem-
bered that the synovial joint is an organ and OA is organ failure that can be
initiated by abnormalities arising in any of its tissues. The authors believe
that the lack of focus on the loss of the habitually loaded contact area of
the joint and on aberrant loading have misdirected the therapeutic efforts
in OA.
How OA is viewed matters because of the implications for treatment
of patients. The authors attribute the lack of success in developing struc-
ture-modifying OA drugs to the fact that OA, from its earliest stages and
in whichever joint it occurs, is mechanically induced. A variety of mechanical
abnormalities can trigger the many processes involved in repair, and attempts
to contain the mechanical insult without a return to mechanical normality
will fail. Drugs cannot initiate this repair. The authors believe that it is very
554 BRANDT et al
unlikely that a drug that inhibits a specific enzyme or cytokine in the path-
ways of cartilage breakdown or that further stimulates the already increased
synthesis of cartilage matrix molecules by the chondrocytes will solve the
problem of OA as long as the joint remains in the same adverse mechanical
environment that got it into trouble in the first place. In addition, because
the subchondral bone is critical for containment of the mechanical abnormal-
ities that damage the cartilage, emphasis on cartilage repair alone is likely to
be futile. If the abnormal stresses on the joint are corrected, pharmacologic
intervention with a structure-modifying drug may be superfluous. Also, there
is no assurance that a drug that slowed the progression of structural damage
in an OA joint will have a beneficial effect on symptoms.
The authors suggest that the genes whose identification will be required
to prevent and treat cases of OA that do not follow significant (macro) joint
trauma will not be those that regulate chondrocyte metabolism but instead
those that control developmental and congenital joint deformities, that
reduce the area of the habitually loaded surface, or that underlie micro-
incoordination, resulting in the concentration of peak dynamic loads that
lead to cumulative tissue microdamage and to remodeling that is detrimen-
tal to joint function.
References
[1] Brandt KD, Mankin HJ, Shulman LE. Workshop on etiopathogenesis of osteoarthritis.
J Rheumatol 1986;13:1126–60.
[2] Kuettner K, Goldberg VM. Introduction. In: Kuettner K, Goldberg VM, editors. Osteoar-
thritic disorders. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1995.
p. xxi–v.
[3] Knowlton RG, Katzenstein PL, Moskowitz RW, et al. Genetic linkage of a polymorphism
in the type II procollagen gene (COL 2A1) to primary osteoarthritis associated with mild
chondrodysplasia. N Engl J Med 1990;322:526–30.
[4] Radin EL, Burr DB, Caterson B, et al. Mechanical determinants of osteoarthrosis. Semin
Arthritis Rheum 1991;21(Suppl 2):12–21.
[5] Radin EL, Burr DB. Hypothesis: joints can heal. Sem Arthr Rheum 1984;13:293–302.
[6] Radin EL, Yang KH, Riegger C, et al. Relationship between lower limb dynamics and knee
joint pain. J Orthop Res 1991;9:398–405.
[7] Radin EL, Paul IL, Pollock D. Animal joint behavior under excessive loading. Nature 1970;
226:554–5.
[8] Convery FR, Akeson WH, Keown GH. The repair of large osteochondral defects. An
experimental study in horses. Clin Orthop Relat Res 1972;82:253–62.
[9] Palmoski M, Brandt KD. Immobilization of the knee prevents osteoarthritis after anterior
cruciate ligament transaction. Arthritis Rheum 1982;25:1201–8.
[10] Brandt KD, Radin EL, Dieppe PA, et al. Yet more evidence that OA is not a cartilage
disease. Ann Rheum Dis 2006;65:1261–4.
[11] Doherty M, Watt I, Dieppe P. Influence of primary generalized osteoarthritis on develop-
ment of secondary osteoarthritis. Lancet 1983;2:8–11.
[12] Schouten JSAG, van den Ouweland FA, Valkenburg HA. A twelve-year follow-up study in
the general population on prognostic factors of cartilage loss in osteoarthritis of the knee.
Ann Rheum Dis 1992;51:932–7.
ETIOPATHOGENESIS OF OSTEOARTHRITIS 555
[13] Smythe HA. The mechanical pathogenesis of generalized osteoarthritis. J Rheumatol 1983;
10(Suppl 9):10–2.
[14] American College of Rheumatology clinical slide collection. Atlanta (GA): American
College of Rheumatology; 1972–2004.
[15] Hernborg J, Nilsson BE. The relationship between osteophytes in the knee joints, osteoar-
thritis and aging. Acta Orthop Scand 1973;44:69–74.
[16] Radin EL. Osteoarthrosis: a perspective. Acta Orthop Scand 1995;66(Suppl 266):6–9.
[17] Weinstein SL. Long-term follow-up of pediatric orthopaedic conditions. Natural history
and outcomes of treatment. J Bone Joint Surg Am 2000;82:980–90.
[18] Fitzgerald JB, Jin M, Dean D, et al. Mechanical compression of cartilage explants induces
multiple time-dependent gene expression patterns and involves intracellular calcium and
cyclic AMP. J Biol Chem 2004;279:19502–11.
[19] Radin EL, Boyd RD, Martin RB, et al. Mechanical factors influencing cartilage damage.
In: Peyron JG, editor. Osteoarthritis: current clinical and fundamental problems. Paris:
Geigy; 1985. p. 90–9.
[20] Jones CM, Watt DG. Muscular control of landing from unexpected falls in man. J Physiol
1971;219:729–37.
[21] Lee JH, Fitzgerald JB, Dimmico MA, et al. Mechanical injury of cartilage explants causes
specific time-dependant changes in chondrocyte gene expression. Arthritis Rheum 2005;52:
2386–95.
[22] Lee JH, Bai Y, Flannery CR, et al. Cartilage mechanical injury and co-culture with joint
capsule tissue increase abundance of ADAMTS-5 protein and aggrecan-G1-NITEGE
product. Transactions of the Orthopedic Research Society 2006;31.
[23] Stokes M, Young A. The contribution of reflex inhibition to arthrogenous muscle weak-
ness. Clin Sci 1984;67:7–14.
[24] Felson DT, Kim Y. The futility of current approaches to chondroprotection. Arthritis
Rheum 2007;56:1378–83.
[25] Brandt KD, Radin EL, Dieppe PA, et al. The futility of current approaches to chondropro-
tectionda different perspective: comment on the special article by Felson and Kim [letter].
Arthritis Rheum 2007;56:3873–4.
[26] Myers SL, Flusser D, Brandt KD, et al. Prevalence of cartilage shards in synovium and their
association with synovitis in patients with early and end stage osteoarthritis. J Rheumatol
1992;19:1247–51.
[27] Burr DR, Schaffler MB. The involvement of subchondral mineralized tissues in osteoarth-
rosis: quantitative microscopic evidence. Microsc Res Tech 1997;37:353–7.
[28] Burr DB, Radin EL. Microfractures and microcracks in subchondral bone: are they rele-
vant to osteoarthrosis. Rheum Dis Clin North Am 2003;29:675–85.
[29] Meachim G, Bentley G. Horizontal splitting in patellar articular cartilage. Arthritis Rheum
1978;21:669–74.
[30] Pauwels F. Biomechanics of the normal and diseased hip: theoretical foundation, technique
and results of treatment. Berlin: Springer-Verlag; 1976. p. 129–268.
[31] Maquet P, Radin EL. Osteotomy as an alternative to total hip replacement in young adults.
Clin Orthop 1977;123:138–42.
[32] Hill AV. Production and absorption of work by muscle. Science 1960;131:897–903.
[33] Radin EL. Role of muscles in protecting athletes from injury. In: Astrand PO, Grimby G,
editors. Physical activity in health and disease. Acta Med Scand 1986;2(Suppl 711):143–7.
[34] Radin EL, Yang KH, Whittle MW, et al. The generation and transmission of heelstrike tran-
sient and the effect of quadriceps paralysis. In: Harris D, editor. Gait analysis and medical
photogrammetry. Oxford (UK): Oxford Orthopaedic Engineering Centre; 1987. p. 34–45.
[35] Hurley MV. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis
Clin North Am 1999;25:299–314.
[36] Slemenda C, Brandt KD, Heilman D, et al. Quadriceps weakness and osteoarthritis of the
knee. Ann Intern Med 1997;127:97–104.
556 BRANDT et al
[37] Slemenda C, Heilman D, Brandt KD, et al. Reduced quadriceps strength relative to body
weight: a risk factor for knee osteoarthritis in women? Arthritis Rheum 1998;41:1951–9.
[38] Brandt KD, Heilman DK, Slemenda C, et al. Quadriceps strength in women with radio-
graphically progressive osteoarthritis of the knee and those with stable radiographic
changes. J Rheumatol 1999;26:2431–7.
[39] Radin EL, Paul IL. Does cartilage compliance reduce skeletal impact loads? The relative
force-attenuating properties of articular cartilage, synovial fluid, periarticular soft tissues
and bone. Arthritis Rheum 1970;13:139–44.
[40] Burr DB. Subchondral bone in the pathogenesis of osteoarthritis. Mechanical aspects. In:
Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. 2nd edition. Oxford (UK):
Oxford University Press; 2003. p. 125–33.
[41] Hayes WC, Swenson LW Jr, Schurman DJ. Axisymmetric finite element analysis of the
lateral tibial plateau. J Biomech 1978;11:21–33.
[42] Mente P, Lewis JL. The elastic modulus of calcified cartilage is an order of magnitude less
than that of subchondral bone. J Orthop Res 1994;12:637–47.
[43] Redler I, Mow VC, Zimny ML, et al. The ultrastructure and biomechanical significance of
the tidemark of articular cartilage. Clin Orthop 1975;112:357–62.
[44] Radin EL, Paul IL. A consolidated concept of joint lubrication. J Bone Joint Surg Am 1972;
54:607–16.
[45] Finlay JB, Repo RU. Cartilage impact in vitro: effect of bone and cement. J Biomech 1978;
11:379–88.
[46] Radin EL, Paul IL, Lowy M. A comparison of the dynamic force transmitting properties of
subchondral bone and articular cartilage. J Bone Joint Surg Am 1970;52:444–56.
[47] Hoshino A, Wallace WA. Impact-absorbing properties of the human knee 1987. J Bone
Joint Surg 1987;69B:807–11.
[48] Burr DB. The importance of subchondral bone in the progression of osteoarthritis. J Rheu-
matol 2004;31(Suppl 70):77–80.
[49] Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from
the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:
247–54.
[50] Grynpas MD, Alpert B, Katz I, et al. Subchondral bone in osteoarthritis. Calcif Tissue Int
1991;49:20–6.
[51] Brown TD, Radin EL, Martin RB, et al. Finite element studies of some juxtarticular stress
changes due to localized subchondral stiffening. J Biomech 1984;17:11–24.
[52] Vener MJ, Thompson RC Jr, Lewis JL, et al. Subchondral damage after acute transartic-
ular loading: an in vitro model of joint injury. J Orthop Res 1992;10:759–65.
[53] McCrae F, Shouls J, Dieppe P, et al. Scintigraphic assessment of osteoarthritis of the knee
joint. Ann Rheum Dis 1992;51:938–42.
[54] Franchi A, Bullough PG. Secondary avascular necrosis in coxarthrosis: a morphologic
study. J Rheumatol 1992;19:1263–8.
[55] Newberry WN, Zukosky OK, Haut RC. Subfracture insult to a knee joint causes alter-
ations in the bone and in the functional stiffness of overlying cartilage. J Orthop Res
1997;15:450–5.
[56] Dedrick OK, Goulet R, Huston L, et al. Early bone changes in experimental osteoarthritis
using microscopic computer tomography. J Rheumatol 1991;18(Suppl 27):44–5.
[57] Dedrick OK, Goldstein SA, Brandt KD, et al. A longitudinal study of subchondral plate and
trabecular bone in cruciate-deficient dogs with osteoarthritis followed for up to 54 months.
Arthritis Rheum 1993;36:1460–7.
[58] Myers SL. Effects of a bisphosphonate on bone histomorphometry and dynamics in the
canine cruciate-deficiency model of osteoarthritis. J Rheumatol 1999;26:2546–53.
[59] Liang MH. Pushing the limits of patient-oriented outcome measurements in the search for
disease modifying treatments for osteoarthritis. J Rheumatol Suppl 2004;31:61–5.
[60] Hadler NM. Knee pain is the maladydnot osteoarthritis. Ann Intern Med 1992;116:598–9.
ETIOPATHOGENESIS OF OSTEOARTHRITIS 557
[61] Massardo L, Watt I, Cushnaghan J, et al. Osteoarthritis of the knee joint: an eight year
prospective study. Ann Rheum Dis 1989;48:893–7.
[62] Lawrence JS, Bremmer JM, Bier F. Osteo-arthrosis. Prevalence in the population and
relationship between symptoms and x-ray changes. Ann Rheum Dis 1966;25:1–24.
[63] Lawrence JS. Osteoarthrosis. In: Lawrence JS, editor. Rheumatism in populations.
London: Heinemann Medical Books, Ltd.; 1977. p. 98–155.
[64] Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the
elderly. Arthritis Rheum 1987;30:914–8.
[65] Sandell LS, Heinegard D, Hering TM. Cell biology, biochemistry, and molecular biology of
articular cartilage in osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, et al,
editors. Osteoarthritis. 4th edition. Philadelphia: Lippincott Willams and Wilkins; 2007.
p. 73–106.
[66] Poole AR, Guilak F, Abramson SB. Etiopathogenesis of osteoarthritis. In: Moskowitz
RW, Altman RD, Hochberg MC, et al, editors. Osteoarthritis. 4th edition. Philadelphia:
Lippincott Williams and Wilkins; 2007. p. 27–49.
[67] Sandy J. Proteolytic degradation of normal and osteoarthritic cartilage matrix. In: Brandt
KD, Doherty M, Lohmander LS, editors. Osteoarthritis. 2nd edition. Oxford (UK): Oxford
University Press; 2003. p. 82–92.
[68] O’Reilly SC, Muir KR, Doherty M. Knee pain and disability in the Nottingham commu-
nity: association with poor health status and psychological distress. Br J Rheumatol
1998;57:588–94.
[69] Evans CH, Mears DC, McKnight JL. A preliminary ferrographic survey of the wear
particles in human synovial fluid. Arthritis Rheum 1981;24:912–8.
[70] Evans CH. Cellular mechanisms of hydrolytic enzyme release in osteoarthritis. Semin
Arthritis Rheum 1981;11(Suppl 1):93–5.
[71] Boniface RJ, Cain PR, Evans CH. Articular responses to purified cartilage proteoglycans.
Arthritis Rheum 1998;31:258–66.
[72] Schumacher HR, Gordon G, Paul H, et al. Osteoarthritis, crystal deposition and inflamma-
tion. Semin Arthritis Rheum 1981;11:116–9.
[73] Jasin HE. Immune mechanisms in osteoarthritis. Semin Arthritis Rheum 1989;18(Suppl 2):
86–90.
[74] Myers SL, Brandt KD, Ehlich JW, et al. Synovial inflammation in patients with early oste-
oarthritis of the knee. J Rheumatol 1990;17:1662–9.
[75] Hill CL, Gale DG, Chaisson CE, et al. Knee effusions, popliteal cysts and synovial thick-
ening. Association with knee pain in those with and without osteoarthritis. J Rheumatol
2001;28:1330–7.
[76] Hill CL, Hunter DJ, Niu J, et al. Synovitis detected on magnetic resonance imaging and its
relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007;66:1599–603.
[77] Lo G, McAlindon T, Niu J, et al. Strong association of bone marrow lesions and effusion
with pain in osteoarthritis. Arthritis Rheum 2007;56(Suppl):S790.
[78] Arnoldi CC, Linderholm H, Mussbichler H. Venous engorgement and intraosseous hyper-
tension in osteoarthritis of the hip. J Bone Joint Surg 1972;54B:409–21.
[79] Arnoldi CC, Lempberg RK, Linderholm H. Immediate effect of osteotomy on the intrame-
dullary pressure of the femoral head and neck in patients with degenerative osteoarthritis.
Acta Orthop Scand 1971;42:357–65.
[80] Arnoldi CC, Djurhuus JC, Heerfordt J, et al. Intraosseous phlebography, intraosseous
pressure measurements and 99m Tc-polyphosphate scintigraphy in patients with various
painful conditions in the hip and knee. Acta Orthop Scand 1980;51:19–28.
[81] McAlindon TEM, Watt I, McCrae F, et al. Magnetic resonance imaging in osteoarthritis of
the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis 1991;
50:14–9.
[82] Dieppe P, Cushnaghan J, Young P, et al. Prediction of the progression of joint space narrowing
in osteoarthritis of the knee with bone scintigraphy. Ann Rheum Dis 1993;52:557–63.
558 BRANDT et al
[83] Hunter DJ, Niu J, Zhang Y, et al. Altered perfusion and venous hypertension is present in
regions of bone affected by BMLs in knee OA. Osteoarthritis Cartilage 2007;15(Suppl C):
C171.
[84] Zanetti M, Bruder E, Romero J, et al. Bone marrow edema pattern in osteoarthritic knees:
correlation between MR imaging and histologic findings. Radiology 2000;215:835–40.
[85] Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progres-
sion of knee osteoarthritis. Ann Intern Med 2003;139:330–6.
[86] Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain
in knee osteoarthritis. Ann Intern Med 2001;134:541–9.
[87] Meizer R, Radda C, Stolz G, et al. MRI-controlled analysis of 104 patients with painful
bone marrow edema in different joint locations treated with the prostacyclin analogue
iloprost. Wien Klin Wochenschr 2005;8:278–86.
[88] Aigner N, Petje G, Schneider W, et al. Bone marrow edema syndrome of the femoral head:
treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-
controlled study. Wien Klin Wochenschr 2005;117:130–5.
[89] Felson DT, Niu J, Guermazi A, et al. Correlation of the development of knee pain with
enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum 2007;
56:2986–92.
[90] Lo G, Hunter D, Nevitt M, et al. Strong association of meniscal maceration and bone
marrow lesions in osteoarthritis. Arthritis Rheum 2007;56(Suppl):S125.
[91] Felson DT. Preventing knee and hip osteoarthritis. Bull Rheum Dis 1998;47:1–4.
[92] Bergennud H, Johnell O, Redlund-Johnell I, et al. The articular cartilage after osteotomy
for gonarthrosis: biopsies after 2 years in 19 cases. Acta Orthop Scand 1992;63:413–6.
[93] Langlais F, Roure JL, Maquet P. Valgus osteotomy in severe osteoarthritis of the hip.
J Bone Joint Surg 1979;61B:424–31.
[94] Warden SJ, Hinman RS, Watson MA Jr, et al. Patellar taping and bracing for the treatment
of chronic knee pain: a systematic review and meta-analysis. Arthritis Rheum 2008;59:73–83.
[95] Niu J, Zhang YQ, Nevitt M, et al. Patellar malalignment is associated with prevalent
patellofemoral osteoarthritis: the Beijing osteoarthritis study. Arthritis Rheum 2005;
52(Suppl 9):S456–7.
[96] Maquet P. Biomechanics of the knee. With application to the pathogenesis and the surgical
treatment of osteoarthritis. Berlin: Springer; 1984. p. 144–56; 279–82.
[97] Intema F, van Roermund PM, Castelein RM, et al. Joint distraction in the treatment of knee
osteoarthritis; the first clinical results. Osteoarthritis Cartilage 2007;15(Suppl C):C234.
[98] Aldegheri R, Trivella G, Saleh M. Articulated distraction of the hip: conservative surgery
for arthritis in young patients. Clin Orthop Relat Res 1994;301:94–101.
[99] Marijnissen AC, Van Roermund PM, van Melkebeek J, et al. Arthritis Rheum 2002;46:
2893–902.
[100] Paley D, Lamm BM. Ankle joint distraction. Foot Ankle Clin 2005;10:685–98.
[101] Ploegmakers JJ, van Roermund PM, van Melkebeek J, et al. Prolonged clinical benefit from
joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage 2005;13:
582–8.
[102] Minor MA. Exercise for the patient with osteoarthritis. In: Brandt KD, Doherty M,
Lohmander LS, editors. Osteoarthritis. 2nd edition. Oxford (UK): Oxford University
Press; 2003. p. 299–310.
[103] Minor MA. Impact of exercise on osteoarthritis outcomes. J Rheumatol 2004;31(Suppl 70):
81–6.
[104] Birmingham TB, Hunt MA, Jones IC, et al. Test-retest reliability of the peak knee adduc-
tion moment during walking in patients with medial compartment knee osteoarthritis.
Arthritis Rheum 2007;57:1012–7.
[105] Baliunas AJ, Hurwitz DE, Ryals AB, et al. Increased knee joint loads during walking are
present in subjects with knee osteoarthritis. Osteoarthritis Cartilage 2002;10:573–9.
ETIOPATHOGENESIS OF OSTEOARTHRITIS 559
[106] Mundermann A, Dyrby CO, Hurwitz DE, et al. Potential strategies to reduce medial com-
partment loading in patients with knee osteoarthritis of varying severity: reduced walking
speed. Arthritis Rheum 2004;50:11172–8.
[107] Miyazaki T, Wada M, Kawahara H, et al. Dynamic load at baseline can predict radio-
graphic disease progression in medial compartment knee osteoarthritis. Ann Rheum Dis
2002;61:617–22.
[108] Amin S, Luepongsak N, McGibbon CA, et al. Knee adduction moment and development
of chronic knee pain in elders. Arthritis Rheum 2004;51:371–6.
[109] Chang A, Hurwitz D, Dunlop D, et al. The relationship between toe-out angle during gait
and progression of medial tibiofemoral osteoarthritis. Ann Rheum Dis 2007;66:1271–5.
[110] Thorp LE, Sumner DR, Wimmer MA, et al. Relationship between pain and medial knee
joint loading in mild radiographic knee osteoarthritis. Arthritis Rheum 2007;57:1254–60.
[111] Shakoor N, Block JA. Walking barefoot decreases loading on the lower extremity joints in
knee osteoarthritis. Arthritis Rheum 2006;54:2923–7.
[112] Shakoor N, Lidtke RH, Sengupta M, et al. Mobility footwear reduces dynamic loads in
subjects with osteoarthritis of the knee. Osteoarthritis Cartilage 2007;15:C219.
[113] Schnitzer TJ, Popovich JM, Andersson GB, et al. Effect of piroxicam on gait in patients
with osteoarthritis of the knee. Arthritis Rheum 1993;36:1207–13.